Displaying 21–30 of 615 for “Visions 2020”
Feb 21, 2019
ReNeuron, a cellular therapy developer in the UK, has reported vision improvements in the treated eyes of the first three retinitis pigmentosa (RP) patients in the Phase II part of the Phase I/II clinical trial for its proprietary human retinal progenitor cells (hRPC). The Phase I portion of the trial, completed last year, primarily assessed safety in subjects with minimal remaining vision.
Aug 2, 2016
Both approaches show strong, near-term potential for providing meaningful vision to people who are otherwise blind from retinal diseases such as retinitis pigmentosa and age-related macular degeneration (AMD).
Aug 29, 2013
How the Retina Adapts to Central Vision Loss
In honor of October Blindness Awareness Month, I will be participating in the Foundation Fighting Blindness’ #ShareYourVision campaign. My vision story began at birth (December 1988), and shortly after, when my family suspected that I may not have been able to see.
May 12, 2022
The national conference will be held on June 17–18, featuring sessions with the latest research advancements, practical adapting and thriving, and an opportunity to connect with the blind and low vision community.
Mar 28, 2012
Because measuring changes is not always easy, people in clinical trials often undergo a number of different tests over one or several years. It can be challenging for the patient, but is necessary to determine if a treatment is working.
The Vision Warriors Endurance Program is committed to taking on the challenge of ending vision loss and pushing beyond our limits through fun, active and challenging programs to support the Foundation Fighting Blindness mission.
VISIONS 2022, the national conference of the Foundation Fighting Blindness, is a one-of-a-kind event in which individuals who are visually impaired, and their families, have the opportunity to hear about exciting advancements in blindness research.
Jul 26, 2017
The high-tech, vision-restoring system interfaces with the visual cortex, the back of the brain where visual input is processed to create the images we see.
Dec 19, 2016
By changing the identity of cells in the retina–namely rods–researchers may someday be able to slow or halt vision loss for those with retinitis pigmentosa (RP) and other related conditions.